|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
|
|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||
| Net income | ||
| Depreciation of plant and equipment | ||
| Amortization of operating lease right-of-use assets | ||
| Expected credit loss allowance | ||
| Impairment loss on trade receivables | ||
| Changes in assets and liabilities: | ||
| Accounts receivable | ||
| Deposits and other current assets | ||
| Accounts payable and other payables | ||
| Deferred tax assets | ||
| Contract liabilities | ||
| Amounts due (to) from related parties | ||
| Amount due from beneficial shareholder | ||
| Operating lease liabilities | ||
| Income tax receivable/payable | ||
| Net cash generated from operating activities | ||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||
| Purchase of plant and equipment | ||
| Prepayment of an internal-use system development contract | ||
| Net cash used in investing activities | ||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||
| Deferred IPO costs | ||
| Payments of offering costs for IPO | ||
| Proceeds from issuance of shares pursuant to IPO | ||
| Advance from related parties | ||
| Repayments to related parties | ||
| Net cash generated from (used) in financing activities | ||
| Net increase in cash and cash equivalents and restricted cash | ||
| Effect of foreign currency translation on cash and cash equivalents | ||
| Cash and cash equivalents and restricted cash, beginning of year | ||
| Cash and cash equivalents and restricted cash, end of year | ||
| Non-cash investing and financing activities: | ||
| Right-of-use assets obtained in exchange for new operating lease obligations | ||
| Offset amount due from a beneficial owner and amounts due to a related party | ||
| Supplementary cash flow information: | ||
| Taxes paid | ||
| Interest received |
Loading...
